nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGS2—Risedronate—Paget's disease of bone	0.599	1	CbGbCtD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.00436	0.0635	CbGpPWpGaD
Sulindac—Tubulointerstitial nephritis—Pamidronate—Paget's disease of bone	0.00341	0.0103	CcSEcCtD
Sulindac—MAPK3—Cellular response to heat stress—VCP—Paget's disease of bone	0.00336	0.049	CbGpPWpGaD
Sulindac—Vertigo—Tiludronate—Paget's disease of bone	0.00329	0.00991	CcSEcCtD
Sulindac—Myalgia—Tiludronate—Paget's disease of bone	0.00312	0.00939	CcSEcCtD
Sulindac—Arthralgia—Tiludronate—Paget's disease of bone	0.00312	0.00939	CcSEcCtD
Sulindac—Pleural effusion—Zoledronate—Paget's disease of bone	0.00311	0.00937	CcSEcCtD
Sulindac—Arthritis—Etidronic acid—Paget's disease of bone	0.003	0.00903	CcSEcCtD
Sulindac—Glossitis—Risedronate—Paget's disease of bone	0.00298	0.00897	CcSEcCtD
Sulindac—Photosensitivity—Alendronate—Paget's disease of bone	0.00283	0.00851	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.00273	0.0082	CcSEcCtD
Sulindac—Proteinuria—Zoledronate—Paget's disease of bone	0.00271	0.00817	CcSEcCtD
Sulindac—Protein urine present—Zoledronate—Paget's disease of bone	0.00268	0.00805	CcSEcCtD
Sulindac—Colitis—Risedronate—Paget's disease of bone	0.00264	0.00793	CcSEcCtD
Sulindac—Dyspepsia—Tiludronate—Paget's disease of bone	0.00263	0.00793	CcSEcCtD
Sulindac—Gastritis—Etidronic acid—Paget's disease of bone	0.00258	0.00776	CcSEcCtD
Sulindac—Hyperkalaemia—Pamidronate—Paget's disease of bone	0.00256	0.00772	CcSEcCtD
Sulindac—Ecchymosis—Risedronate—Paget's disease of bone	0.00248	0.00747	CcSEcCtD
Sulindac—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00245	0.00736	CcSEcCtD
Sulindac—Pancytopenia—Etidronic acid—Paget's disease of bone	0.00239	0.0072	CcSEcCtD
Sulindac—Hyperkalaemia—Zoledronate—Paget's disease of bone	0.00234	0.00705	CcSEcCtD
Sulindac—Gastroenteritis—Risedronate—Paget's disease of bone	0.00225	0.00677	CcSEcCtD
Sulindac—MAPK3—GMCSF-mediated signaling events—INPP5D—Paget's disease of bone	0.00224	0.0326	CbGpPWpGaD
Sulindac—Toxic epidermal necrolysis—Alendronate—Paget's disease of bone	0.00224	0.00673	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Etidronic acid—Paget's disease of bone	0.00223	0.0067	CcSEcCtD
Sulindac—Neuropathy peripheral—Etidronic acid—Paget's disease of bone	0.0022	0.00663	CcSEcCtD
Sulindac—Gastritis—Alendronate—Paget's disease of bone	0.0022	0.00662	CcSEcCtD
Sulindac—Asthenia—Tiludronate—Paget's disease of bone	0.00215	0.00646	CcSEcCtD
Sulindac—Agranulocytosis—Etidronic acid—Paget's disease of bone	0.0021	0.00631	CcSEcCtD
Sulindac—Cardiac failure congestive—Pamidronate—Paget's disease of bone	0.00209	0.00629	CcSEcCtD
Sulindac—Arthritis—Risedronate—Paget's disease of bone	0.00205	0.00617	CcSEcCtD
Sulindac—Diarrhoea—Tiludronate—Paget's disease of bone	0.00205	0.00616	CcSEcCtD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—BGLAP—Paget's disease of bone	0.00203	0.0296	CbGpPWpGaD
Sulindac—Dizziness—Tiludronate—Paget's disease of bone	0.00198	0.00595	CcSEcCtD
Sulindac—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.00196	0.0059	CcSEcCtD
Sulindac—MAPK3—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00193	0.0281	CbGpPWpGaD
Sulindac—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.00191	0.00574	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Alendronate—Paget's disease of bone	0.0019	0.00571	CcSEcCtD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.0019	0.0276	CbGpPWpGaD
Sulindac—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.00189	0.0057	CcSEcCtD
Sulindac—Headache—Tiludronate—Paget's disease of bone	0.00187	0.00564	CcSEcCtD
Sulindac—Stomatitis—Alendronate—Paget's disease of bone	0.00187	0.00562	CcSEcCtD
Sulindac—MAPK3—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.00185	0.027	CbGpPWpGaD
Sulindac—Renal impairment—Zoledronate—Paget's disease of bone	0.00182	0.00547	CcSEcCtD
Sulindac—MAPK3—IL-3 Signaling Pathway—INPP5D—Paget's disease of bone	0.00179	0.0261	CbGpPWpGaD
Sulindac—Alopecia—Etidronic acid—Paget's disease of bone	0.00178	0.00536	CcSEcCtD
Sulindac—Arthritis—Zoledronate—Paget's disease of bone	0.00178	0.00536	CcSEcCtD
Sulindac—PPARD—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.00178	0.0259	CbGpPWpGaD
Sulindac—Nausea—Tiludronate—Paget's disease of bone	0.00178	0.00535	CcSEcCtD
Sulindac—Gastritis—Risedronate—Paget's disease of bone	0.00176	0.00531	CcSEcCtD
Sulindac—Muscular weakness—Risedronate—Paget's disease of bone	0.00176	0.00529	CcSEcCtD
Sulindac—Flatulence—Etidronic acid—Paget's disease of bone	0.00173	0.00521	CcSEcCtD
Sulindac—MAPK3—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00173	0.0252	CbGpPWpGaD
Sulindac—Gastritis—Pamidronate—Paget's disease of bone	0.00168	0.00505	CcSEcCtD
Sulindac—MAPK3—IL-4 Signaling Pathway—INPP5D—Paget's disease of bone	0.00166	0.0241	CbGpPWpGaD
Sulindac—Erythema multiforme—Alendronate—Paget's disease of bone	0.00162	0.00489	CcSEcCtD
Sulindac—Anaemia—Etidronic acid—Paget's disease of bone	0.00162	0.00488	CcSEcCtD
Sulindac—Bronchospasm—Pamidronate—Paget's disease of bone	0.00161	0.00485	CcSEcCtD
Sulindac—Angioedema—Etidronic acid—Paget's disease of bone	0.0016	0.00483	CcSEcCtD
Sulindac—Sweating increased—Pamidronate—Paget's disease of bone	0.0016	0.0048	CcSEcCtD
Sulindac—MAPK3—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00159	0.0231	CbGpPWpGaD
Sulindac—MAPK3—Antiviral mechanism by IFN-stimulated genes—NUP205—Paget's disease of bone	0.00158	0.023	CbGpPWpGaD
Sulindac—Leukopenia—Etidronic acid—Paget's disease of bone	0.00157	0.00473	CcSEcCtD
Sulindac—Pneumonia—Risedronate—Paget's disease of bone	0.00154	0.00465	CcSEcCtD
Sulindac—MAPK3—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00154	0.0225	CbGpPWpGaD
Sulindac—Gastritis—Zoledronate—Paget's disease of bone	0.00153	0.00461	CcSEcCtD
Sulindac—Depression—Risedronate—Paget's disease of bone	0.00153	0.00461	CcSEcCtD
Sulindac—Neutropenia—Pamidronate—Paget's disease of bone	0.00153	0.00461	CcSEcCtD
Sulindac—Muscular weakness—Zoledronate—Paget's disease of bone	0.00153	0.00459	CcSEcCtD
Sulindac—Alopecia—Alendronate—Paget's disease of bone	0.00152	0.00457	CcSEcCtD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.0015	0.0219	CbGpPWpGaD
Sulindac—Arthralgia—Etidronic acid—Paget's disease of bone	0.00149	0.0045	CcSEcCtD
Sulindac—Conjunctivitis—Risedronate—Paget's disease of bone	0.00149	0.00449	CcSEcCtD
Sulindac—Discomfort—Etidronic acid—Paget's disease of bone	0.00148	0.00444	CcSEcCtD
Sulindac—Flatulence—Alendronate—Paget's disease of bone	0.00147	0.00444	CcSEcCtD
Sulindac—Bronchospasm—Zoledronate—Paget's disease of bone	0.00147	0.00443	CcSEcCtD
Sulindac—Pneumonia—Pamidronate—Paget's disease of bone	0.00147	0.00442	CcSEcCtD
Sulindac—Dysgeusia—Alendronate—Paget's disease of bone	0.00146	0.00441	CcSEcCtD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00146	0.0213	CbGpPWpGaD
Sulindac—MAPK3—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.00146	0.0213	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—PML—Paget's disease of bone	0.00146	0.0213	CbGpPWpGaD
Sulindac—Sweating increased—Zoledronate—Paget's disease of bone	0.00146	0.00439	CcSEcCtD
Sulindac—Renal failure—Pamidronate—Paget's disease of bone	0.00144	0.00432	CcSEcCtD
Sulindac—Stomatitis—Pamidronate—Paget's disease of bone	0.00142	0.00428	CcSEcCtD
Sulindac—Pancytopenia—Zoledronate—Paget's disease of bone	0.00142	0.00428	CcSEcCtD
Sulindac—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00142	0.00427	CcSEcCtD
Sulindac—Neutropenia—Zoledronate—Paget's disease of bone	0.0014	0.00421	CcSEcCtD
Sulindac—MAPK3—BCR signaling pathway—INPP5D—Paget's disease of bone	0.00139	0.0203	CbGpPWpGaD
Sulindac—Haematuria—Pamidronate—Paget's disease of bone	0.00139	0.00419	CcSEcCtD
Sulindac—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00139	0.00418	CcSEcCtD
Sulindac—Anaemia—Alendronate—Paget's disease of bone	0.00138	0.00416	CcSEcCtD
Sulindac—Angioedema—Alendronate—Paget's disease of bone	0.00137	0.00411	CcSEcCtD
Sulindac—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00136	0.0041	CcSEcCtD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.00136	0.0198	CbGpPWpGaD
Sulindac—Malaise—Alendronate—Paget's disease of bone	0.00135	0.00406	CcSEcCtD
Sulindac—MAPK3—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—Paget's disease of bone	0.00135	0.0196	CbGpPWpGaD
Sulindac—Vertigo—Alendronate—Paget's disease of bone	0.00134	0.00404	CcSEcCtD
Sulindac—Depression—Zoledronate—Paget's disease of bone	0.00133	0.004	CcSEcCtD
Sulindac—PPARD—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00131	0.0191	CbGpPWpGaD
Sulindac—Renal failure—Zoledronate—Paget's disease of bone	0.00131	0.00395	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00131	0.00393	CcSEcCtD
Sulindac—Stomatitis—Zoledronate—Paget's disease of bone	0.0013	0.00391	CcSEcCtD
Sulindac—Conjunctivitis—Zoledronate—Paget's disease of bone	0.0013	0.0039	CcSEcCtD
Sulindac—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00129	0.00387	CcSEcCtD
Sulindac—Tinnitus—Risedronate—Paget's disease of bone	0.00129	0.00387	CcSEcCtD
Sulindac—Chest pain—Alendronate—Paget's disease of bone	0.00127	0.00383	CcSEcCtD
Sulindac—Myalgia—Alendronate—Paget's disease of bone	0.00127	0.00383	CcSEcCtD
Sulindac—Haematuria—Zoledronate—Paget's disease of bone	0.00127	0.00383	CcSEcCtD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TNFRSF11B—Paget's disease of bone	0.00127	0.0185	CbGpPWpGaD
Sulindac—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00126	0.0038	CcSEcCtD
Sulindac—Discomfort—Alendronate—Paget's disease of bone	0.00126	0.00379	CcSEcCtD
Sulindac—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00124	0.00375	CcSEcCtD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.00124	0.018	CbGpPWpGaD
Sulindac—Arrhythmia—Risedronate—Paget's disease of bone	0.00123	0.00371	CcSEcCtD
Sulindac—Constipation—Etidronic acid—Paget's disease of bone	0.00123	0.00369	CcSEcCtD
Sulindac—Flushing—Pamidronate—Paget's disease of bone	0.00122	0.00366	CcSEcCtD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—INPP5D—Paget's disease of bone	0.00121	0.0176	CbGpPWpGaD
Sulindac—Flatulence—Risedronate—Paget's disease of bone	0.00118	0.00356	CcSEcCtD
Sulindac—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00118	0.00355	CcSEcCtD
Sulindac—Chills—Pamidronate—Paget's disease of bone	0.00118	0.00354	CcSEcCtD
Sulindac—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00117	0.00353	CcSEcCtD
Sulindac—Alopecia—Pamidronate—Paget's disease of bone	0.00116	0.00349	CcSEcCtD
Sulindac—Urticaria—Etidronic acid—Paget's disease of bone	0.00114	0.00343	CcSEcCtD
Sulindac—Tension—Pamidronate—Paget's disease of bone	0.00112	0.00337	CcSEcCtD
Sulindac—Dysgeusia—Pamidronate—Paget's disease of bone	0.00112	0.00336	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00111	0.00335	CcSEcCtD
Sulindac—Flushing—Zoledronate—Paget's disease of bone	0.00111	0.00334	CcSEcCtD
Sulindac—Anaemia—Risedronate—Paget's disease of bone	0.00111	0.00334	CcSEcCtD
Sulindac—Nervousness—Pamidronate—Paget's disease of bone	0.00111	0.00334	CcSEcCtD
Sulindac—Angioedema—Risedronate—Paget's disease of bone	0.0011	0.0033	CcSEcCtD
Sulindac—Vertigo—Risedronate—Paget's disease of bone	0.00108	0.00325	CcSEcCtD
Sulindac—Syncope—Risedronate—Paget's disease of bone	0.00108	0.00324	CcSEcCtD
Sulindac—Dyspepsia—Alendronate—Paget's disease of bone	0.00107	0.00323	CcSEcCtD
Sulindac—Chills—Zoledronate—Paget's disease of bone	0.00107	0.00323	CcSEcCtD
Sulindac—Arrhythmia—Zoledronate—Paget's disease of bone	0.00107	0.00322	CcSEcCtD
Sulindac—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00106	0.00319	CcSEcCtD
Sulindac—Alopecia—Zoledronate—Paget's disease of bone	0.00106	0.00318	CcSEcCtD
Sulindac—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00106	0.00318	CcSEcCtD
Sulindac—Loss of consciousness—Risedronate—Paget's disease of bone	0.00105	0.00318	CcSEcCtD
Sulindac—Anaemia—Pamidronate—Paget's disease of bone	0.00105	0.00317	CcSEcCtD
Sulindac—Constipation—Alendronate—Paget's disease of bone	0.00104	0.00314	CcSEcCtD
Sulindac—Angioedema—Pamidronate—Paget's disease of bone	0.00104	0.00314	CcSEcCtD
Sulindac—Hypertension—Risedronate—Paget's disease of bone	0.00104	0.00312	CcSEcCtD
Sulindac—Malaise—Pamidronate—Paget's disease of bone	0.00103	0.0031	CcSEcCtD
Sulindac—Syncope—Pamidronate—Paget's disease of bone	0.00102	0.00308	CcSEcCtD
Sulindac—Chest pain—Risedronate—Paget's disease of bone	0.00102	0.00308	CcSEcCtD
Sulindac—Myalgia—Risedronate—Paget's disease of bone	0.00102	0.00308	CcSEcCtD
Sulindac—Arthralgia—Risedronate—Paget's disease of bone	0.00102	0.00308	CcSEcCtD
Sulindac—Leukopenia—Pamidronate—Paget's disease of bone	0.00102	0.00307	CcSEcCtD
Sulindac—Dysgeusia—Zoledronate—Paget's disease of bone	0.00102	0.00307	CcSEcCtD
Sulindac—Pruritus—Etidronic acid—Paget's disease of bone	0.00101	0.00305	CcSEcCtD
Sulindac—Feeling abnormal—Alendronate—Paget's disease of bone	0.00101	0.00303	CcSEcCtD
Sulindac—Loss of consciousness—Pamidronate—Paget's disease of bone	0.001	0.00302	CcSEcCtD
Sulindac—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000998	0.003	CcSEcCtD
Sulindac—Convulsion—Pamidronate—Paget's disease of bone	0.000989	0.00298	CcSEcCtD
Sulindac—Hypertension—Pamidronate—Paget's disease of bone	0.000985	0.00296	CcSEcCtD
Sulindac—Vision blurred—Zoledronate—Paget's disease of bone	0.000982	0.00296	CcSEcCtD
Sulindac—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00098	0.00295	CcSEcCtD
Sulindac—Myalgia—Pamidronate—Paget's disease of bone	0.000971	0.00292	CcSEcCtD
Sulindac—Arthralgia—Pamidronate—Paget's disease of bone	0.000971	0.00292	CcSEcCtD
Sulindac—Urticaria—Alendronate—Paget's disease of bone	0.00097	0.00292	CcSEcCtD
Sulindac—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.000967	0.00291	CcSEcCtD
Sulindac—Body temperature increased—Alendronate—Paget's disease of bone	0.000965	0.0029	CcSEcCtD
Sulindac—Shock—Risedronate—Paget's disease of bone	0.000964	0.0029	CcSEcCtD
Sulindac—Anaemia—Zoledronate—Paget's disease of bone	0.000963	0.0029	CcSEcCtD
Sulindac—Discomfort—Pamidronate—Paget's disease of bone	0.00096	0.00289	CcSEcCtD
Sulindac—Angioedema—Zoledronate—Paget's disease of bone	0.000952	0.00287	CcSEcCtD
Sulindac—MAPK3—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.000951	0.0139	CbGpPWpGaD
Sulindac—Malaise—Zoledronate—Paget's disease of bone	0.00094	0.00283	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—CALCA—Paget's disease of bone	0.000937	0.0137	CbGpPWpGaD
Sulindac—Vertigo—Zoledronate—Paget's disease of bone	0.000936	0.00282	CcSEcCtD
Sulindac—Syncope—Zoledronate—Paget's disease of bone	0.000935	0.00281	CcSEcCtD
Sulindac—Leukopenia—Zoledronate—Paget's disease of bone	0.000933	0.00281	CcSEcCtD
Sulindac—Oedema—Pamidronate—Paget's disease of bone	0.000931	0.0028	CcSEcCtD
Sulindac—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.000931	0.0028	CcSEcCtD
Sulindac—MAPK3—Mitotic Prophase—NUP205—Paget's disease of bone	0.000927	0.0135	CbGpPWpGaD
Sulindac—Palpitations—Zoledronate—Paget's disease of bone	0.000921	0.00277	CcSEcCtD
Sulindac—Shock—Pamidronate—Paget's disease of bone	0.000916	0.00276	CcSEcCtD
Sulindac—Loss of consciousness—Zoledronate—Paget's disease of bone	0.000916	0.00276	CcSEcCtD
Sulindac—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000912	0.00274	CcSEcCtD
Sulindac—Vomiting—Etidronic acid—Paget's disease of bone	0.000911	0.00274	CcSEcCtD
Sulindac—Tachycardia—Pamidronate—Paget's disease of bone	0.000909	0.00274	CcSEcCtD
Sulindac—Rash—Etidronic acid—Paget's disease of bone	0.000903	0.00272	CcSEcCtD
Sulindac—Convulsion—Zoledronate—Paget's disease of bone	0.000903	0.00272	CcSEcCtD
Sulindac—Dermatitis—Etidronic acid—Paget's disease of bone	0.000903	0.00272	CcSEcCtD
Sulindac—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.0009	0.00271	CcSEcCtD
Sulindac—Hypertension—Zoledronate—Paget's disease of bone	0.0009	0.00271	CcSEcCtD
Sulindac—Hypersensitivity—Alendronate—Paget's disease of bone	0.000899	0.00271	CcSEcCtD
Sulindac—Headache—Etidronic acid—Paget's disease of bone	0.000898	0.0027	CcSEcCtD
Sulindac—ALB—Folate Metabolism—CSF1—Paget's disease of bone	0.000895	0.013	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000892	0.00269	CcSEcCtD
Sulindac—Anorexia—Pamidronate—Paget's disease of bone	0.000888	0.00267	CcSEcCtD
Sulindac—Chest pain—Zoledronate—Paget's disease of bone	0.000887	0.00267	CcSEcCtD
Sulindac—Arthralgia—Zoledronate—Paget's disease of bone	0.000887	0.00267	CcSEcCtD
Sulindac—Myalgia—Zoledronate—Paget's disease of bone	0.000887	0.00267	CcSEcCtD
Sulindac—Insomnia—Risedronate—Paget's disease of bone	0.000886	0.00267	CcSEcCtD
Sulindac—Paraesthesia—Risedronate—Paget's disease of bone	0.00088	0.00265	CcSEcCtD
Sulindac—Discomfort—Zoledronate—Paget's disease of bone	0.000877	0.00264	CcSEcCtD
Sulindac—Asthenia—Alendronate—Paget's disease of bone	0.000876	0.00264	CcSEcCtD
Sulindac—Dyspnoea—Risedronate—Paget's disease of bone	0.000873	0.00263	CcSEcCtD
Sulindac—Hypotension—Pamidronate—Paget's disease of bone	0.00087	0.00262	CcSEcCtD
Sulindac—Pruritus—Alendronate—Paget's disease of bone	0.000864	0.0026	CcSEcCtD
Sulindac—Dyspepsia—Risedronate—Paget's disease of bone	0.000862	0.0026	CcSEcCtD
Sulindac—MAPK3—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000852	0.0124	CbGpPWpGaD
Sulindac—Nausea—Etidronic acid—Paget's disease of bone	0.000851	0.00256	CcSEcCtD
Sulindac—MAPK3—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000851	0.0124	CbGpPWpGaD
Sulindac—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.000851	0.00256	CcSEcCtD
Sulindac—Oedema—Zoledronate—Paget's disease of bone	0.000851	0.00256	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000848	0.00255	CcSEcCtD
Sulindac—Fatigue—Risedronate—Paget's disease of bone	0.000845	0.00254	CcSEcCtD
Sulindac—Insomnia—Pamidronate—Paget's disease of bone	0.000842	0.00253	CcSEcCtD
Sulindac—Constipation—Risedronate—Paget's disease of bone	0.000838	0.00252	CcSEcCtD
Sulindac—Shock—Zoledronate—Paget's disease of bone	0.000837	0.00252	CcSEcCtD
Sulindac—Paraesthesia—Pamidronate—Paget's disease of bone	0.000836	0.00252	CcSEcCtD
Sulindac—Diarrhoea—Alendronate—Paget's disease of bone	0.000835	0.00251	CcSEcCtD
Sulindac—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000833	0.00251	CcSEcCtD
Sulindac—Dyspnoea—Pamidronate—Paget's disease of bone	0.00083	0.0025	CcSEcCtD
Sulindac—Tachycardia—Zoledronate—Paget's disease of bone	0.00083	0.0025	CcSEcCtD
Sulindac—Somnolence—Pamidronate—Paget's disease of bone	0.000828	0.00249	CcSEcCtD
Sulindac—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000822	0.00247	CcSEcCtD
Sulindac—Dyspepsia—Pamidronate—Paget's disease of bone	0.00082	0.00247	CcSEcCtD
Sulindac—Anorexia—Zoledronate—Paget's disease of bone	0.000811	0.00244	CcSEcCtD
Sulindac—Decreased appetite—Pamidronate—Paget's disease of bone	0.000809	0.00244	CcSEcCtD
Sulindac—Dizziness—Alendronate—Paget's disease of bone	0.000807	0.00243	CcSEcCtD
Sulindac—Fatigue—Pamidronate—Paget's disease of bone	0.000803	0.00242	CcSEcCtD
Sulindac—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.000801	0.00241	CcSEcCtD
Sulindac—Constipation—Pamidronate—Paget's disease of bone	0.000796	0.0024	CcSEcCtD
Sulindac—Hypotension—Zoledronate—Paget's disease of bone	0.000795	0.00239	CcSEcCtD
Sulindac—MAPK3—Interferon Signaling—NUP205—Paget's disease of bone	0.000779	0.0114	CbGpPWpGaD
Sulindac—Urticaria—Risedronate—Paget's disease of bone	0.000778	0.00234	CcSEcCtD
Sulindac—Vomiting—Alendronate—Paget's disease of bone	0.000776	0.00234	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000775	0.00233	CcSEcCtD
Sulindac—Body temperature increased—Risedronate—Paget's disease of bone	0.000774	0.00233	CcSEcCtD
Sulindac—Rash—Alendronate—Paget's disease of bone	0.00077	0.00232	CcSEcCtD
Sulindac—Insomnia—Zoledronate—Paget's disease of bone	0.000769	0.00232	CcSEcCtD
Sulindac—Dermatitis—Alendronate—Paget's disease of bone	0.000769	0.00231	CcSEcCtD
Sulindac—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000767	0.00231	CcSEcCtD
Sulindac—Headache—Alendronate—Paget's disease of bone	0.000765	0.0023	CcSEcCtD
Sulindac—Paraesthesia—Zoledronate—Paget's disease of bone	0.000764	0.0023	CcSEcCtD
Sulindac—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000761	0.00229	CcSEcCtD
Sulindac—Dyspnoea—Zoledronate—Paget's disease of bone	0.000758	0.00228	CcSEcCtD
Sulindac—Somnolence—Zoledronate—Paget's disease of bone	0.000756	0.00228	CcSEcCtD
Sulindac—Dyspepsia—Zoledronate—Paget's disease of bone	0.000749	0.00225	CcSEcCtD
Sulindac—Decreased appetite—Zoledronate—Paget's disease of bone	0.000739	0.00223	CcSEcCtD
Sulindac—Body temperature increased—Pamidronate—Paget's disease of bone	0.000736	0.00222	CcSEcCtD
Sulindac—Fatigue—Zoledronate—Paget's disease of bone	0.000733	0.00221	CcSEcCtD
Sulindac—Constipation—Zoledronate—Paget's disease of bone	0.000727	0.00219	CcSEcCtD
Sulindac—Nausea—Alendronate—Paget's disease of bone	0.000725	0.00218	CcSEcCtD
Sulindac—Hypersensitivity—Risedronate—Paget's disease of bone	0.000722	0.00217	CcSEcCtD
Sulindac—MAPK3—Cellular responses to stress—VCP—Paget's disease of bone	0.000714	0.0104	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—NUP205—Paget's disease of bone	0.000711	0.0104	CbGpPWpGaD
Sulindac—Asthenia—Risedronate—Paget's disease of bone	0.000703	0.00212	CcSEcCtD
Sulindac—Feeling abnormal—Zoledronate—Paget's disease of bone	0.000701	0.00211	CcSEcCtD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000696	0.0101	CbGpPWpGaD
Sulindac—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000696	0.00209	CcSEcCtD
Sulindac—Pruritus—Risedronate—Paget's disease of bone	0.000693	0.00209	CcSEcCtD
Sulindac—MAPK3—Interferon Signaling—PML—Paget's disease of bone	0.000689	0.01	CbGpPWpGaD
Sulindac—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000686	0.00206	CcSEcCtD
Sulindac—MAPK3—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000677	0.00987	CbGpPWpGaD
Sulindac—Urticaria—Zoledronate—Paget's disease of bone	0.000676	0.00203	CcSEcCtD
Sulindac—Body temperature increased—Zoledronate—Paget's disease of bone	0.000672	0.00202	CcSEcCtD
Sulindac—Diarrhoea—Risedronate—Paget's disease of bone	0.00067	0.00202	CcSEcCtD
Sulindac—Asthenia—Pamidronate—Paget's disease of bone	0.000668	0.00201	CcSEcCtD
Sulindac—Pruritus—Pamidronate—Paget's disease of bone	0.000659	0.00198	CcSEcCtD
Sulindac—Dizziness—Risedronate—Paget's disease of bone	0.000648	0.00195	CcSEcCtD
Sulindac—Diarrhoea—Pamidronate—Paget's disease of bone	0.000637	0.00192	CcSEcCtD
Sulindac—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000627	0.00189	CcSEcCtD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000624	0.0091	CbGpPWpGaD
Sulindac—Vomiting—Risedronate—Paget's disease of bone	0.000623	0.00187	CcSEcCtD
Sulindac—Rash—Risedronate—Paget's disease of bone	0.000618	0.00186	CcSEcCtD
Sulindac—Dermatitis—Risedronate—Paget's disease of bone	0.000617	0.00186	CcSEcCtD
Sulindac—Dizziness—Pamidronate—Paget's disease of bone	0.000616	0.00185	CcSEcCtD
Sulindac—Headache—Risedronate—Paget's disease of bone	0.000614	0.00185	CcSEcCtD
Sulindac—Asthenia—Zoledronate—Paget's disease of bone	0.00061	0.00184	CcSEcCtD
Sulindac—AKR1B1—Metabolism—INPP5D—Paget's disease of bone	0.000606	0.00883	CbGpPWpGaD
Sulindac—Pruritus—Zoledronate—Paget's disease of bone	0.000602	0.00181	CcSEcCtD
Sulindac—Vomiting—Pamidronate—Paget's disease of bone	0.000592	0.00178	CcSEcCtD
Sulindac—Rash—Pamidronate—Paget's disease of bone	0.000587	0.00177	CcSEcCtD
Sulindac—Dermatitis—Pamidronate—Paget's disease of bone	0.000587	0.00177	CcSEcCtD
Sulindac—Headache—Pamidronate—Paget's disease of bone	0.000583	0.00176	CcSEcCtD
Sulindac—Diarrhoea—Zoledronate—Paget's disease of bone	0.000582	0.00175	CcSEcCtD
Sulindac—Nausea—Risedronate—Paget's disease of bone	0.000582	0.00175	CcSEcCtD
Sulindac—Dizziness—Zoledronate—Paget's disease of bone	0.000562	0.00169	CcSEcCtD
Sulindac—Nausea—Pamidronate—Paget's disease of bone	0.000553	0.00166	CcSEcCtD
Sulindac—Vomiting—Zoledronate—Paget's disease of bone	0.000541	0.00163	CcSEcCtD
Sulindac—Rash—Zoledronate—Paget's disease of bone	0.000536	0.00161	CcSEcCtD
Sulindac—Dermatitis—Zoledronate—Paget's disease of bone	0.000536	0.00161	CcSEcCtD
Sulindac—Headache—Zoledronate—Paget's disease of bone	0.000533	0.0016	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00053	0.00772	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.00052	0.00758	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000511	0.00745	CbGpPWpGaD
Sulindac—Nausea—Zoledronate—Paget's disease of bone	0.000505	0.00152	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—VCP—Paget's disease of bone	0.000501	0.0073	CbGpPWpGaD
Sulindac—MAPK3—M Phase—NUP205—Paget's disease of bone	0.000499	0.00727	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000493	0.00718	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.000481	0.00702	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CALCA—Paget's disease of bone	0.000481	0.00701	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.00046	0.0067	CbGpPWpGaD
Sulindac—MAPK3—Mitotic M-M/G1 phases—NUP205—Paget's disease of bone	0.000457	0.00666	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000444	0.00647	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—OPTN—Paget's disease of bone	0.00043	0.00627	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000398	0.0058	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000391	0.0057	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000371	0.00541	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.000342	0.00498	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NUP205—Paget's disease of bone	0.000331	0.00482	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—NUP205—Paget's disease of bone	0.000306	0.00446	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000293	0.00426	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CALCA—Paget's disease of bone	0.000284	0.00414	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—INPP5D—Paget's disease of bone	0.000276	0.00403	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000266	0.00387	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.00026	0.00378	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NUP205—Paget's disease of bone	0.000257	0.00375	CbGpPWpGaD
Sulindac—PPARD—Metabolism—INPP5D—Paget's disease of bone	0.000219	0.0032	CbGpPWpGaD
Sulindac—MAPK3—Disease—VCP—Paget's disease of bone	0.000205	0.00299	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000188	0.00275	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NUP205—Paget's disease of bone	0.00017	0.00248	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NUP205—Paget's disease of bone	0.000169	0.00246	CbGpPWpGaD
Sulindac—MAPK3—Disease—NUP205—Paget's disease of bone	0.000157	0.00229	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PML—Paget's disease of bone	0.00015	0.00219	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.00015	0.00218	CbGpPWpGaD
Sulindac—MAPK3—Immune System—INPP5D—Paget's disease of bone	0.000145	0.00211	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VCP—Paget's disease of bone	0.000144	0.00209	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CALCA—Paget's disease of bone	0.000138	0.00201	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000135	0.00197	CbGpPWpGaD
Sulindac—ALB—Hemostasis—INPP5D—Paget's disease of bone	0.000133	0.00194	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000133	0.00194	CbGpPWpGaD
Sulindac—MAPK3—Immune System—SQSTM1—Paget's disease of bone	0.00013	0.00189	CbGpPWpGaD
Sulindac—PTGS2—Disease—VCP—Paget's disease of bone	0.000122	0.00178	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000121	0.00176	CbGpPWpGaD
Sulindac—MAPK3—Disease—CALCA—Paget's disease of bone	0.000116	0.0017	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NUP205—Paget's disease of bone	9.84e-05	0.00143	CbGpPWpGaD
Sulindac—PTGS2—Disease—NUP205—Paget's disease of bone	9.33e-05	0.00136	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	8.47e-05	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SQSTM1—Paget's disease of bone	8.4e-05	0.00122	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—INPP5D—Paget's disease of bone	8.39e-05	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CALCA—Paget's disease of bone	8.16e-05	0.00119	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NUP205—Paget's disease of bone	7.81e-05	0.00114	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NUP205—Paget's disease of bone	6.94e-05	0.00101	CbGpPWpGaD
Sulindac—PTGS2—Disease—CALCA—Paget's disease of bone	6.93e-05	0.00101	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INPP5D—Paget's disease of bone	6.66e-05	0.000971	CbGpPWpGaD
Sulindac—ALB—Metabolism—NUP205—Paget's disease of bone	6.32e-05	0.000921	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INPP5D—Paget's disease of bone	5.91e-05	0.000862	CbGpPWpGaD
Sulindac—ALB—Metabolism—INPP5D—Paget's disease of bone	5.39e-05	0.000786	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NUP205—Paget's disease of bone	4.42e-05	0.000644	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INPP5D—Paget's disease of bone	3.77e-05	0.000549	CbGpPWpGaD
